Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Ptc Therapeutics (PTCT) Intangibles (2017 - 2025)

Ptc Therapeutics has reported Intangibles over the past 9 years, most recently at $388.8 million for Q4 2025.

  • Quarterly results put Intangibles at $388.8 million for Q4 2025, changed N/A from a year ago — trailing twelve months through Dec 2025 was $388.8 million (changed N/A YoY), and the annual figure for FY2025 was $388.8 million, changed.
  • Intangibles for Q4 2025 was $388.8 million at Ptc Therapeutics, down from $396.5 million in the prior quarter.
  • Over the last five years, Intangibles for PTCT hit a ceiling of $763.7 million in Q1 2022 and a floor of $118.4 million in Q1 2025.
  • Median Intangibles over the past 5 years was $451.6 million (2023), compared with a mean of $503.4 million.
  • Biggest five-year swings in Intangibles: surged 55.62% in 2022 and later crashed 64.11% in 2025.
  • Ptc Therapeutics' Intangibles stood at $453.6 million in 2021, then soared by 55.62% to $705.9 million in 2022, then crashed by 46.24% to $379.5 million in 2023, then fell by 12.95% to $330.4 million in 2024, then rose by 17.67% to $388.8 million in 2025.
  • The last three reported values for Intangibles were $388.8 million (Q4 2025), $396.5 million (Q3 2025), and $143.8 million (Q2 2025) per Business Quant data.